Heat · Cold · Infrared · Sauna · Recovery · Longevity
These are not rivals. They target different biology through different mechanisms and their evidence bases are distinct. Finnish sauna has 20-year prospective mortality data from 2,315 men. Cold exposure has documented neuroendocrine effects. Far-infrared therapy has growing clinical evidence for cardiovascular and musculoskeletal conditions. Here is what the evidence actually says about each — and why the sauna vs cold argument misses the point.
The Kuopio Ischaemic Heart Disease Risk Factor Study is one of the most compelling lifestyle-medicine datasets in the literature. 2,315 Finnish men followed for an average of 20 years, with sauna habits documented at baseline. The cardiovascular findings are striking and dose-dependent.
Men who used a sauna 2–3 times per week had 22% lower cardiovascular mortality compared to those who used it once per week. Men who used it 4–7 times per week had 40% lower cardiovascular mortality. All-cause mortality followed the same dose-response pattern: 4+ sessions per week, 40% lower all-cause mortality. These are not weak associations in a small study — they are large effects in a substantial cohort with 20 years of follow-up, replicated across multiple analyses and extended to women in subsequent research.
Temperature: 80–100°C (traditional Finnish sauna). Lower temperatures in infrared sauna produce similar physiological responses at longer durations.
Duration: 15–20 minutes per session. The 20-minute threshold appears important for heat shock protein induction.
Frequency: The mortality data favours 4+ sessions per week for maximum cardiovascular benefit. Even 2–3 sessions weekly produces significant risk reduction.
Hydration: 500ml water before, water during if needed, 1L+ after. Electrolyte replacement (particularly sodium, magnesium, potassium) is important with regular use given sweat losses.
The mechanism of cold exposure benefit is better characterised than its critics acknowledge and more modest than its advocates claim. The most robust finding is the noradrenaline response: cold water immersion (14°C water for 1–3 minutes) produces a 300–500% increase in plasma noradrenaline concentration that is sustained for 2–4 hours post-exposure. Noradrenaline drives attention, focus, mood elevation, metabolic activity, and fat mobilisation.
This is a real, measurable, clinically significant neuroendocrine response. It is not placebo. It is not selective reporting. The noradrenaline spike from cold exposure is comparable to that produced by moderate exercise and is one of the few reliable ways to rapidly elevate noradrenaline without pharmacological intervention.
Cold water immersion produces acute cardiovascular stress — cold shock response, vasoconstriction, and the diving reflex produce a rapid rise in blood pressure and cardiac demand. This is contraindicated in: uncontrolled hypertension, recent cardiac events, Raynaud's disease, cryoglobulinaemia, and cold urticaria. Anyone with cardiovascular risk factors should discuss with their GP before beginning regular cold immersion protocols.
Post-DVT clients — such as the client mentioned in clinic — should be particularly cautious. Cold-induced vasoconstriction followed by reactive vasodilation when rewarming could theoretically affect venous dynamics in someone with a recent thrombotic event. This is a case for GP discussion before implementation.
Far-infrared (FIR) radiation (wavelengths >3000nm, typically 5000–100,000nm in therapeutic devices) is distinct from the near-infrared used in photobiomodulation panels. FIR penetrates soft tissue to a depth of 2–7cm and produces thermal effects through vibration of water molecules in tissue — a different mechanism from NIR photobiomodulation (which operates via cytochrome c oxidase photochemistry at minimal thermal effect).
Far-infrared saunas operate at lower ambient temperatures (50–60°C) than traditional Finnish saunas (80–100°C) but achieve comparable core temperature increases over longer sessions. For those who cannot tolerate the high ambient temperature of a traditional sauna — elderly individuals, those with respiratory conditions, those with heat intolerance — far-infrared sauna provides a lower-temperature route to similar physiological effects.
Clinical evidence for far-infrared specifically includes: congestive heart failure (multiple Japanese RCTs showing improved exercise tolerance, reduced hospitalisations, and reduced mortality in CHF patients using FIR sauna); chronic pain and fibromyalgia (multiple small RCTs showing pain and fatigue reduction); and rheumatoid arthritis (short-term symptom improvement in Dutch RCTs). The cardiovascular evidence in CHF specifically is striking enough that FIR sauna is used as adjunctive cardiac rehabilitation in Japan.
The consumer market has blurred several distinct technologies under the "infrared" label:
Near-infrared red light panels (630–850nm) — photobiomodulation devices. Mechanism: cytochrome c oxidase photochemistry. Non-thermal. Used at specific doses (mW/cm² × time = J/cm² dose). This is the technology with the most specific mechanistic evidence. See the Sound, Light and Colour Therapy post for detail.
Far-infrared sauna cabins — use FIR emitters (ceramic or carbon elements) to heat the body directly at lower ambient temperatures than conventional sauna. Mechanism: thermal, via FIR tissue penetration. Evidence: cardiovascular, musculoskeletal, fatigue-related conditions.
Infrared saunas marketed as "full spectrum" — claim to combine near-infrared, mid-infrared, and far-infrared in a single cabin. The near-infrared component in these units is typically at much lower irradiance than dedicated red light panels and is unlikely to deliver the photobiomodulation dose demonstrated in PBM research. The thermal benefits from the FIR component are genuine; the photobiomodulation claims are often overstated.
The internet argument between sauna advocates and cold exposure advocates is a category error. These two modalities target different physiological systems through different mechanisms and are not mutually exclusive.
The answer to "sauna or cold?" is almost always "both, used appropriately for different purposes at different times." The Finnish sauna data for cardiovascular and neurological mortality reduction is the more compelling long-term investment. Cold exposure for the acute noradrenaline/dopamine response is a genuinely useful daily practice for mood, focus, and metabolic activation. They are complementary tools, not competing ideologies.
A 40% reduction in cardiovascular mortality from 4+ sauna sessions per week is one of the largest lifestyle-associated mortality reductions in the published literature. It has been known since the Kuopio data was published. It is underutilised clinically and underappreciated publicly.
DunedinPACE — the DNA methylation clock that measures your current pace of ageing — is sensitive to lifestyle interventions including regular sauna use and cold exposure. Retest at 12 months to measure whether your biological age is moving in the right direction.
DH Longevity Investigation →